The research team set out to test a hypothesis that has been gathering support for more than a decade: that the composition of the gut microbiome is not merely a bystander in metabolic disease but an active participant in determining where and how the body stores energy. To do this, the investigators combined detailed profiling of gut bacterial communities with metabolic measurements in experimental models of visceral fat accumulation, tracking which bacterial taxa rose or fell in abundance as visceral fat expanded and which microbial functions changed in parallel. Their analysis converged on a set of key bacterial species whose abundance correlated with visceral fat mass and whose gene expression signatures pointed to the glycogen synthesis pathway as a central mechanistic link.

Glycogen synthesis is one of the oldest and most conserved energy-storage strategies in biology. In animals, glycogen is stored primarily in the liver and muscle, where it serves as a rapidly mobilizable reservoir of glucose. In bacteria, glycogen and related glucans serve as energy reserves that help microbes survive nutrient fluctuation in the fluctuating chemical environment of the gut. What the new study highlights is that this ancient bacterial pathway may have consequences for the host that extend well beyond the intestinal wall. When specific gut bacteria ramp up glycogen synthesis, they alter the balance of carbohydrates and short-chain fatty acids in the gut lumen, and these metabolites can be absorbed by the host and channeled into fat deposition, particularly in visceral depots.

The researchers found that the abundance of particular bacterial taxa was consistently associated with visceral fat accumulation across their experimental cohorts. By characterizing the functional potential of these microbes through metagenomic and transcriptomic approaches, the team showed that genes involved in glycogen synthesis and glucan metabolism were enriched in the bacterial communities linked to larger visceral fat stores. This pattern suggests a model in which glycogen-accumulating bacteria act as a kind of metabolic sponge, sequestering carbohydrates in the gut and reshaping the flow of energy between the microbiome and the host. The metabolic output of these bacteria, including the profile of short-chain fatty acids they generate, appears to influence host lipid handling in ways that favor deposition of energy in visceral rather than subcutaneous fat.

One of the most intriguing implications of this work concerns the mechanistic bridge between bacterial metabolism and host physiology. Short-chain fatty acids such as acetate, propionate and butyrate are produced when gut bacteria ferment dietary fiber and other carbohydrates, and they are known to influence appetite regulation, insulin secretion and lipid synthesis through both hormonal and neural signaling pathways. The new findings suggest that the glycogen synthesis pathway modulates how much carbohydrate is available for this fermentation and in what proportions the different fatty acids are produced. By shifting this microbial metabolite profile, glycogen-accumulating taxa may indirectly program host tissues to prioritize visceral fat storage, creating a feedback loop in which expanding fat depots further alter the gut environment and consolidate the dominance of the bacterial taxa that initiated the process.

The study also contributes to a growing rethinking of how visceral fat disease should be understood and treated. For years, the dominant clinical narrative has centered on caloric excess and sedentary behavior, and while those factors remain important, they have never fully explained the variability observed between individuals. The microbiota-centered model advanced by this research suggests that two people consuming identical diets may store that energy very differently depending on which bacterial taxa colonize their intestines and how active their glycogen synthesis machinery is. This framing opens the possibility that modulating the microbiome, whether through targeted probiotics, dietary interventions that favor beneficial taxa, or in the longer term even microbiome-editing approaches, could become a genuine therapeutic strategy for reducing visceral fat and its downstream cardiometabolic risks.

From a technical standpoint, the study exemplifies the multi-omics approach that has come to define modern microbiome science. Rather than cataloging bacterial species by name alone, the researchers integrated taxonomic profiling with functional gene analysis, connecting shifts in community composition to shifts in metabolic capability. This distinction matters because the clinical relevance of a microbiome resides less in which microbes are present and more in what they are doing. A gut community that is rich in glycogen-synthesizing organisms is functionally different from one dominated by taxa that direct carbohydrates toward other ends, even if the species lists overlap substantially. By anchoring their analysis in the glycogen synthesis pathway, the authors identified a concrete, mechanistically interpretable node where microbial activity and host metabolism intersect, a level of specificity that has often been missing from correlational microbiome studies.

The findings also raise questions that the research community will now need to pursue. The work was conducted in experimental models, and the extent to which the same bacterial taxa and pathway dynamics operate in humans remains to be established through longitudinal studies in diverse populations. It is also not yet clear whether manipulating glycogen synthesis in specific gut bacteria would be safe or effective, since the pathway plays roles in microbial fitness that could have unpredictable consequences for gut ecology. Nevertheless, the identification of key bacterial taxa and a defined metabolic pathway offers something that the field has lacked: a testable molecular hypothesis linking visceral fat accumulation to the microbiome, one that can be probed with genetic tools, dietary interventions and metabolite measurements in future work.

As obesity-related metabolic disease continues to rise worldwide, the search for actionable control points beyond diet and exercise has intensified. The gut microbiota has emerged as one of the most promising frontiers in that search, and studies of this kind are converting broad correlations into specific biological mechanisms. By tracing a pathway from bacterial glycogen metabolism through microbial metabolites to the deposition of visceral fat, this research moves the field closer to interventions that could act on the microbiome to reshape where the body stores its energy. Whether such interventions will one day sit alongside diet and exercise in clinical guidelines remains an open question, but the direction of travel in microbiome science is clear, and the glycogen synthesis pathway has now been added to the map of targets worth watching.

Subject of Research: The association between gut microbiota composition and visceral fat accumulation through the bacterial glycogen synthesis pathway

Article Title: Linking visceral fat accumulation to gut microbiota: key bacterial taxa and their roles in the glycogen synthesis pathway

Article References: Kim, N.-E., Cho, B., Kim, Y., Kim, G., Yie, G.-E., Kim, H., Park, J., Kim, H., Jeong, C., Lee, M., Joo, Y., Lim, S., Park, S., Hong, Y., Min, K., Cho, B., Yun, J. M., Jung, E. S., Ji, Y., … Won, S. (2026). Linking visceral fat accumulation to gut microbiota: key bacterial taxa and their roles in the glycogen synthesis pathway. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-026-01828-7

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01828-7

Keywords: gut microbiota, visceral fat, glycogen synthesis, obesity, metabolic disease, short-chain fatty acids, microbiome, insulin resistance, bacterial taxa, lipid metabolism, experimental models, energy storage